Alan and Helene Goldberg In Vitro Toxicology Grants support scientists developing toxicology methods to reduce or replace laboratory animals in biomedical research and product safety testing.
Funder: Johns Hopkins Center for Alternatives to Animal Testing
Due Dates (Anticipated): January 2027 (Application deadline, 2026–2027 session)
Funding Amounts: Up to $40,000 USD in seed funding
Summary: Supports scientists developing toxicology methods that significantly reduce or replace laboratory animals in biomedical research and product safety testing.
Key Information: Refinement proposals are funded through a separate mechanism, not this toxicology grant.
The Johns Hopkins Center for Alternatives to Animal Testing (CAAT) provides seed support for scientists developing alternatives to animal use in biomedical research and product safety testing. This program focuses on implementing the National Academies report Toxicity Testing in the 21st Century: A Vision and a Strategy, with the objective of significantly reducing or replacing laboratory animals.
Supported work can include explaining how human cells respond to toxicants in vitro, developing adverse outcome pathways (AOPs), and conducting systematic reviews. Projects should consider how new methods can translate into evaluating or predicting health outcomes. The grants help researchers demonstrate the value of a line of study and build a foundation for subsequent support from the NIH and other sources.